The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Osteoblast Programmed Cell Death (Apoptosis): Modulation by Growth Factors and Cytokines
Open accessAbstract
Once osteoblasts have completed their bone-forming function, they are either entrapped in bone matrix and become osteocytes or remain on the surface as lining cells. Nonetheless, 50–70% of the osteoblasts initially present at the remodeling site cannot be accounted for after enumeration of lining cells and osteocytes. We hypothesized that the missing osteoblasts die by apoptosis and that growth factors and cytokines produced in the bone microenvironment influence this process. We report that murine osteoblastic MC3T3-E1 cells underwent apoptosis following removal of serum, or addition of tumor necrosis factor (TNF), as indicated by terminal deoxynucleotidyl transferase–mediated dUTP-nick end labeling and DNA fragmentation studies. Transforming growth factor-β and interleukin-6 (IL-6)–type cytokines had antiapoptotic effects because they were able to counteract the effect of serum starvation or TNF. In addition, anti-Fas antibody stimulated apoptosis of human osteoblastic MG-63 cells and IL-6–type cytokines prevented these changes. The induction of apoptosis in MG-63 cells was associated with an increase in the ratio of the proapoptotic protein bax to the antiapoptotic protein bcl-2, and oncostatin M prevented this change. Examination of undecalcified sections of murine cancellous bone revealed the presence of apoptotic cells, identified as osteoblasts by their proximity to osteoid seams and their juxtaposition to cuboidal osteoblasts. Assuming an osteoblast life span of 300 h and a prevalence of apoptosis of 0.6%, we calculated that the fraction that undergo this process in vivo can indeed account for the missing osteoblasts. These findings establish that osteoblasts undergo apoptosis and strongly suggest that the process can be modulated by growth factors and cytokines produced in the bone microenvironment.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“At this stage, the mature osteoblasts can undergo apoptosis or become osteocytes or bone lining cells [47, 48].”
From Biology of Bone Tissue: Structure, Function, and Factors That Influence Bone Cells (2015) · cites this paper as [48]
Citations
Cites
Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation.
Gavrieli, Y., Sherman, Y., & Ben-Sasson, S. A. (1992) · The Journal of cell biology · doi:10.1083/jcb.119.3.493 · Cited by 9,444
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650020617 · Cited by 5,344
Self-citationBone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
PARFITT, A. M., Drezner, M. K., Glorieux, F. H., Kanis, J. А., Malluche, H. H., Meunier, P. J., Ott, S. M., & Recker, R. R. (1987) · Journal of Bone and Mineral Research · Cited by 3,258
Self-citationSuppression of TNF-α-Induced Apoptosis by NF-κB
Antwerp, D. J. V., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Mechanisms and Genes of Cellular Suicide
Steller, H. (1995) · Science · doi:10.1126/science.7878463 · Cited by 2,469
(2019) · Elsevier eBooks · doi:10.1016/c2015-1-01622-2 · Cited by 1,690
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,670
Self-citationCompston, J. E. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.2431019.x · Cited by 1,383
Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D., Mundy, G. R., & Boyce, B. F. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650101008 · Cited by 1,039
Parfitt, A. M. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550303 · Cited by 1,001
Self-citation
Research works printed but not linked: 3
- Arnott, 1995, Evidence for a role of programmed cell death in the regulation of bone formation in adult human bone, J Bone Miner Res, 10, S216
- Parfitt, 1990, Bone, Vol 1: The Osteoblast and Osteocyte, 351
- Bellido, 1997, gp130/STAT3 activation stimulates the transcription of the cyclin dependent kinase inhibitor p21WAF1,CIP1 gene in osteoblasts: A prerequisite for the biologic effects of IL-6 type cytokines, J Bone Miner Res, 12, S159
Cited by
Sorted by citations
Items 401–500 of 577
Wang, R., He, X., Su, S., Bai, J., Xiang, Q., Liu, H., & Zhou, F. (2024) · Smart Materials in Medicine · doi:10.1016/j.smaim.2024.07.002 · Cited by 10
Osteoimmunology and the Osteoblast
Nanes, M. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00005-0 · Cited by 10
NMDA Receptor Hypofunction in the Aging-Associated Malfunction of Peripheral Tissue
Rivera-Villaseñor, A., Higinio-Rodríguez, F., Nava-Gomez, L. J., Vázquez-Prieto, B., Calero-Vargas, I., Olivares-Moreno, R., & López-Hidalgo, M. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.687121 · Cited by 10
The Hypothesis of the Prolonged Cell Cycle in Turner Syndrome
Álvarez‐Nava, F., & Soto-Quintana, M. (2022) · Journal of Developmental Biology · doi:10.3390/jdb10020016 · Cited by 10
“Osteoblasts can have three fates; remaining on the bone surface as bone lining cells, differentiating into osteocytes, or undergoing apoptosis, but apoptosis is the main fate of osteoblasts [83] (Figure 2).”
BackgroundLechler, P., Schaumburger, J., Köck, F. X., Balakrishnan, S., Doukas, S., Prantl, L., & Grifka, J. K. (2011) · Calcified Tissue International · doi:10.1007/s00223-011-9508-y · Cited by 10
Guo, S., Zhu, W., Yin, Z., Ding, X. L., Zhang, Q., Liu, T., Ni, J., Ouyang, Z., & Xie, H. (2019) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000852 · Cited by 10
Programmed cell death in post-traumatic bone callus.
Olmedo, M. L., Landry, P. S., Sadasivan, K. K., Albright, J. A., & Marino, A. A. (2000) · PubMed · Cited by 10
Li, Y., Bäckesjö, C., Haldosén, L.-A., & Lindgren, U. (2008) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2008.09.004 · Cited by 10
Wang, Y., Li, L. Z., Zhang, Y. L., Sun, W. J., Zhu, Y. Q., Cui, Y., & Qi, L. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.06.027 · Cited by 10
“, 1998), and treatments that inhibit it are associated with anti-fracture efficacy (Jilka et al., 1998).”
BackgroundMorimoto, H., Morimoto, Y., Ohba, T., Kido, H., Kobayashi, S., & Haneji, T. (1999) · Journal of Bone and Mineral Metabolism · doi:10.1007/s007740050094 · Cited by 10
“Some osteoblasts initially present at the remodeling site probably die by apoptosis [23].”
BackgroundWitasp, E., Gustafsson, A.-C., Cotgreave, I. A., Lind, M., & Fadeel, B. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.061 · Cited by 10
Chae, H., Chae, S., Park, N., Bang, B.-G., Cho, S., Kim, J., Kim, H.-M., Kim, H., Lee, Z. H., & Kim, H. (2001) · International Immunopharmacology · doi:10.1016/s1567-5769(00)00025-4 · Cited by 10
Göhringer, I., Storrer, C. L. M., Cunha, E. J., Passoni, G. N. D. S., Vieira, J. S., Zielak, J. C., Scariot, R., Deliberador, T. M., & Giovanini, A. F. (2017) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000003617 · Cited by 9
The Treatment of Inflammation, Pain, and Fever Using Medicinal Plants
Akkol, E. K., Das, S., Sarker, S. D., & Nahar, L. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/476985 · Cited by 9
Simulated Interventions to Ameliorate Age-Related Bone Loss Indicate the Importance of Timing
Proctor, C. J., & Gartland, A. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00061 · Cited by 10
Qin, Y., Zhang, Z., Yu, L., He, J., Hou, Y., Liu, T., Wu, J., Wu, S.-H., & Guo, L. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00403.x · Cited by 9
Peng, C., Chow, K., Chang, W., Tsai, C., Lin, T., Lin, S., & Chiu, C.-F. (1999) · American Journal of Hematology · doi:10.1002/(sici)1096-8652(199908)61:4 · Cited by 9
Fromigué, O., Haÿ, E., Barbara, A., Pétrel, C., Traiffort, É., Ruat, M., & Marie, P. J. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00673.x · Cited by 9
Haneji, T. (2005) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.38.1 · Cited by 9
“Alterations in the timing and extent of osteoblast apoptosis could have a significant role on the rate of bone formation, because 50–70% of the osteoblasts initially present at the remodeling site die by apoptosis [27].”
BackgroundBradley, E. W., Westendorf, J. J., van Wijnen, A. J., & Dudakovic, A. (2018) · Wiley eBooks · doi:10.1002/9781119266594.ch4 · Cited by 9
Goonoo, N., & Bhaw‐Luximon, A. (2018) · Journal of materials research/Pratt's guide to venture capital sources · doi:10.1557/jmr.2018.132 · Cited by 9
The effect of TNF-α on osteoblasts in metal wear-induced periprosthetic bone loss
Hameister, R., Lohmann, C. H., Dheen, S. T., Singh, G., & Kaur, C. (2020) · Bone and Joint Research · doi:10.1302/2046-3758.911.bjr-2020-0001.r2 · Cited by 8
Role of MAPKs in TGF-β1-induced maturation and mineralization in human osteoblast-like cells
Wang, T., Watanabe, K., Hamada, N., & Tani‐Ishii, N. (2023) · Journal of Oral Biosciences · doi:10.1016/j.job.2023.12.003 · Cited by 8
Biologic Foundations for Skeletal Tissue Engineering
Bueno, E., & Glowacki, J. (2011) · Synthesis lectures on tissue engineering · doi:10.2200/s00329ed1v01y201101tis007 · Cited by 25
“Only a fraction of osteoblasts become osteocytes, the majority undergoing apoptosis after they secrete the bone ECM [19].”
BackgroundChristiansen, P. V. D., Andreasen, C. M., El-Masri, B. M., Laursen, K. S., Delaissé, J., & Andersen, T. L. (2023) · Bone · doi:10.1016/j.bone.2023.116896 · Cited by 8
Yang, Y., Huang, W., Xie, Q.-M., Xu, Z.-R., Zhao, Q.-J., Wu, X., Li, F., & Dong, X. (2009) · Inflammation Research · doi:10.1007/s00011-009-0082-y · Cited by 8
Detection of Apoptosis of Bone Cells In Vitro
Bellido, T., & Plotkin, L. I. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-104-8_4 · Cited by 8
Self-citationBurr, D. B., Bellido, T., & White, K. E. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-09138-1.00006-1 · Cited by 9
Self-citationTransforming Growth Factor β1 (TGF-β1) in the Sera of Postmenopausal Osteoporotic Females
Faraji, A., Abtahi, S., Ghaderi, A. A., & Dehaghani, A. S. (2016) · Intern J Endocrinol Metab · doi:10.5812/ijem.36511 · Cited by 8
Receptors for Parathyroid Hormone (PTH) and PTH-Related Protein
Gardella, T. J., Jüppner, H., Bringhurst, F. R., & Potts, J. T. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00046-x · Cited by 8
Detection of apoptotic gene expression in human osteoblast-like cells by cDNA microarrays
Razzouk, S., & Shapiro, I. M. (2003) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-003-0419-5 · Cited by 8
“During bone remodeling, there is evidence of extensive osteoblast apoptosis [1,2].”
BackgroundN‐Acetyl Cysteine Regulates TNF‐α‐Inhibited Differentiation in ROS 17/2.8 Osteoblasts
Chae, H., Chae, S., & Kim, H. (2004) · Immunopharmacology and Immunotoxicology · doi:10.1081/iph-120037716 · Cited by 8
“Osteoblasts play a pivotal role in bone remodeling.([1]) Tumor necrosis factor-a (TNF-a), a cytokine synthesized in the bone microenvironment, has pleiotrophic effects on osteoblasts or osteoblasts-like cells.”
BackgroundResearch progress on the regulatory cell death of osteoblasts in periodontitis
Bao, J., Wei, Y., & Chen, L. (2024) · Journal of Zhejiang University (Medical Sciences) · doi:10.3724/zdxbyxb-2024-0038 · Cited by 7
Chen, L., Kadoya, K., Endo, T., Iwasaki, N., & Terkawi, M. A. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.05.002 · Cited by 7
Bone Wasn't Built in a Day: Destruction and Formation of Bone in the Rheumatic Diseases.
Gravallese, E. M. (2017) · Europe PMC (PubMed Central) · Cited by 7
Chandra, A., Rosenzweig, A. B., & Pignolo, R. J. (2018) · Springer eBooks · doi:10.1007/978-3-319-72228-3_1 · Cited by 6
Striated muscle fiber apoptosis after experimental tendon lesion in a rat model
Palumbo, C., Rovesta, C., & Ferretti, M. (2012) · Journal of Anatomy · doi:10.1111/j.1469-7580.2012.01554.x · Cited by 7
“The authors also refer that data are reported in the literature suggesting that osteocyte apoptosis could be involved in triggering bone turnover (Noble et al. 1997; Jilka et al. 1998; Noble & Reeve, 2000); it cannot be excluded that such an improvement of turnover might also occur in other tissues of the locomotor ap…”
BackgroundZhang, Z., Song, C., Zhang, F., Xiang, L., Chen, Y., Li, Y., Pan, J., Liu, H., Xiao, G. G., & Ju, D. (2015) · Nutrients · doi:10.3390/nu7021333 · Cited by 7
“TGF-β1 could suppress osteoblast or osteoclast apoptosis by increasing expression of Bcl-2 family members [31,32].”
BackgroundZhang, J., Xu, S., Zhang, Y., Zou, S., & Li, X. (2018) · European Journal Of Oral Sciences · doi:10.1111/eos.12595 · Cited by 7
Nanes, M. S., & Pacifici, R. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_5 · Cited by 7
Molecular Regulation of Osteoblast Differentiation
Bukka, P. L., McKee, M. D., & Karaplis, A. C. (2004) · Springer eBooks · doi:10.1007/978-1-4471-3777-1_1 · Cited by 7
Christakos, S., Barletta, F., Huening, M., Kohut, J., & Raval-Pandya, M. (2000) · Springer eBooks · doi:10.1007/978-94-010-0688-0_16 · Cited by 7
Forbord, K. M., Lunde, N. N., Bosnjak, T., Johansen, H. T., Solberg, R., & Jafari, A. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1445049 · Cited by 6
“At the cellular level, TGF-b 1 has been shown to enhance osteoblast proliferation (8) and migration of osteogenic cells to the bone forming surfaces (9), while exerting an inhibitory effect on osteoblast apoptosis (10).”
Backgroundvan Leeuwen, J. P. T. M., van der Eerden, B. C. J., van de Peppel, J., Stein, G. S., & Lian, J. B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00009-1 · Cited by 7
Yusop, N., Moseley, R., & Waddington, R. J. (2023) · Frontiers in Dental Medicine · doi:10.3389/fdmed.2023.1200122 · Cited by 6
“Conversely, during the latter stages of repair, TGF-β1 is considered to be an inhibitory factor toward the further differentiation of osteoblasts associated with deposition of the mineralized matrix (22–24), although the further differentiation of osteoblasts into osteocytes is proposed to be aided by TGF-β1 in preven…”
BackgroundBiocompatibility of orthopaedic implants on bone forming cells
Kapanen, A. I. (2002) · Cited by 6
Skeletal Effects of Nitric Oxide
Wimalawansa, S. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373884-4.00007-0 · Cited by 7
Inorganic Biomaterials to Support the Formation and Repair of Bone Tissue
Sullivan, C. O., Kennedy, G., O’Neill, L., Crean, A. M., & Ryan, K. B. (2021) · Royal Society of Chemistry eBooks · doi:10.1039/9781788019293-00242 · Cited by 6
Apoptosis of rat osteoblasts in process of calcification in vitro.
Gu, Q., Zhu, H.-M., & Zhang, X. (2002) · PubMed · Cited by 6
Cellular and Molecular Mechanisms of Postmenopausal Osteoporosis
Manolagas, S. C. (2000) · Springer eBooks · doi:10.1007/978-0-387-21628-7_13 · Cited by 6
Self-citationHeterogeneity of murine periosteum progenitors involved in fracture healingPreprint
Matthews, B. G., Novak, S., Sbrana, F. V., Funnell, J. L., Cao, Y., Buckels, E. J., Grčević, D., & Kalajzić, I. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.24.169003 · Cited by 6
Kannan, R., Carruthers, N. J., Koh, A. J., Kleer, G. G., Nakamura, K., Parker, S. C. J., McCauley, L. K., & Roca, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1650465 · Cited by 5
Marozin, S., Simon‐Nobbe, B., Huth, A., Beyerer, E., Weber, L., Nussler, A. K., & Lepperdinger, G. (2024) · Scientific Reports · doi:10.1038/s41598-024-60986-8 · Cited by 5
Budanur, D. T., Zibandeh, N., Genç, D., Gökalp, M., Kaşalı, K., Akkoç, T., & Sepet, E. (2018) · Dental Traumatology · doi:10.1111/edt.12396 · Cited by 5
Osteogenic potential of laser modified and conditioned titanium zirconium surfaces
Charles, P., Anandapandian, P. A., & Samuel, S. (2016) · The Journal of Indian Prosthodontic Society · doi:10.4103/0972-4052.186403 · Cited by 5
Lian, J. B., & Stein, G. S. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50008-2 · Cited by 5
Lian, J. B., & Stein, G. S. (2006) · Elsevier eBooks · doi:10.1016/b978-012088562-6/50015-7 · Cited by 31
Bishop, R. T., Miller, A., Froid, M., Nerlakanti, N., Li, T., Frieling, J. S., Nasr, M., Nyman, K. J., Sudalagunta, P. R., Canevarolo, R. R., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.11.13.516335 · Cited by 5
Liu, P., Deng, J., Yang, Y., Bai, W., Dong, S., & Zhang, Z. (2025) · iScience · doi:10.1016/j.isci.2025.112107 · Cited by 5
“22,23 Prolonged exposure to IL-1 b in cell culture impairs osteoblast differentiation, as evidenced by compromised alkaline phosphatase expression and impaired bone nodule mineralization.”
Engineering Efferocytosis for Bone Regeneration
Miszuk, J. M., Zhong, L., & Sun, H. (2025) · Macromolecular Bioscience · doi:10.1002/mabi.202500094 · Cited by 5
Receptors Implicated in Microgravity-Induced Bone Loss
Martinez, E. F., Pelegrine, A. A., & Holliday, L. S. (2024) · Receptors · doi:10.3390/receptors3020014 · Cited by 4
“Various other factors regulate osteoblast differentiation including hormones and various cytokines [98–101] (Figure 3A).”
BackgroundZhou, Y.-S., Huang, J., Cao, W., Yu, A.-X., Li, P., Liang, J.-L., Leng, X., Jin, J., Yu, P., & Liu, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1331488 · Cited by 4
“Once osteoclasts stop resorbing bone eventually, they die by apoptosis and removed rapidly by phagocytes duringthe early portion of the reversal phase(57,58),whilesmallchangesinosteoblastapoptosiscanresultin much larger changes in bone formation (59, 60).”
BackgroundThe role of circulating cytokines in colorectal carcinoma
Siragusa, T., Miller, A., Belluco, C., Nitti, D., Lise, M., & Jessup, J. (2000) · International Journal of Clinical Oncology · doi:10.1007/pl00012041 · Cited by 2
“IL-6 also prevents apoptosis in osteoblasts induced by tumor necrosis factor-alpha (TNFα) and serum starvation.(61) The Bcl-2 protein family mediates cell survival or resistance to apoptosis, at least in part.”
BackgroundÁlvarez-Hernández, D., Naves‐Díaz, M., Alonso, C. G., & Cannata-Andía, J. B. (2007) · Revista Española de Enfermedades Metabólicas Óseas · doi:10.1016/s1132-8460(07)73498-0 · Cited by 4
Cytokine-induced osteopoietic differentiation of transplanted marrow cells
Otsuru, S., Rasini, V., Bussolari, R., Hofmann, T. J., Dominici, M., & Horwitz, E. M. (2011) · Blood · doi:10.1182/blood-2011-01-331397 · Cited by 4
Yeo, J., Park, K., Ju, W., Lee, J.-A., Lee, K.-G., Woo, S., Han, S., Kweon, H., Kim, S., & Cho, Y. (2008) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2008.37.8.992 · Cited by 4
“최근 여러 사전연구에서 조골세포가 파골세포의 분화 및 성 숙을 조절할 수 있다고 보고하였다(2).”
Zhang, Z., Chen, Y.-J., Xiang, L., Pan, J., Wang, Z., Xiao, G. G., & Ju, D. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3130 · Cited by 4
“Finally, these cytokines may protect osteoblasts from apoptosis caused by tumor necrosis factor-α (TNF-α) or serum depletion (34).”
BackgroundHo, M., Chang, J., Tsai, H., Cho, M.-H., & Wang, G. (2001) · Journal of Musculoskeletal Research · doi:10.1142/s0218957701000623 · Cited by 4
Gimble, J. M., Floyd, Z. E., Kassem, M. S., & NUTTALL, M. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-25976-5_2 · Cited by 4
Shin, J.-H., Park, J., Yeo, S.-I., Noh, W.-C., Kim, M., Kim, J.-C., & Suh, J. (2007) · The Journal of the Korean Academy of Periodontology · doi:10.5051/jkape.2007.37.suppl.447 · Cited by 4
Sory, D. R., Heyraud, A. C. M., Jones, J. R., & Rankin, S. M. (2024) · Biomaterials Advances · doi:10.1016/j.bioadv.2024.214019 · Cited by 4
Zhao, W., Deng, W., Wang, Y., Zhu, R., Liu, J., Chen, H., Tang, W., Luo, Y., Du, A., Zhu, H., et al. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.117678 · Cited by 3
Parathyroid hormone and parathyroid hormone–related protein actions on bone and kidney
Bisello, A., & Friedman, P. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00027-0 · Cited by 3
Ramasubramanian, A. M., Jeeawoody, S., & Yang, F. (2013) · Drug Delivery and Translational Research · doi:10.1007/s13346-013-0163-x · Cited by 3
“Osteoblasts at the end of the bone formation process have been reported to undergo apoptosis, suggesting a potential role of osteoblast apoptosis in bone formation and remodeling [17].”
BackgroundTrtková, K. S., Luzna, P., Drozdková, D. W., Čížková, K., Janovská, L., Gurský, J., Průková, D., Frydrych, I., Hajdúch, M., & Minařík, J. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12837 · Cited by 3
Houston, J. M. I., Bourebaba, L., Bourebaba, N., Tomal, A., & Marycz, K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1424873 · Cited by 3
“The importance of apoptosis in skeletal tissues and its functional relationship with bone turnover have been recently investigated by various authors to understand whether and, if so, how the mechanism of programmed cell death interferes with bone modelling (23, 25, 26).”
BackgroundPhysiological Regulation of Bone Metabolism and Estrogen Agonism
García‐Pérez, M. Á. (2006) · Springer eBooks · doi:10.1007/3-540-34742-9_7 · Cited by 3
Rosenzweig, A. B., & Pignolo, R. J. (2010) · Humana Press eBooks · doi:10.1007/978-1-60327-467-8_1 · Cited by 3
Nitric Oxide and Other Vasoactive Agents
Buttery, L. D. K., Mancini, L., Moradi‐Bidhendi, N., O'Shaughnessy, M. C., Polak, J. M., & MacIntyre, I. M. (2002) · Elsevier eBooks · doi:10.1016/b978-012098652-1.50157-8 · Cited by 3
In Vitro Regulation of Osteoblast Activity
Karin, N. J., & Farach‐Carson, M. C. (2004) · Springer eBooks · doi:10.1007/978-1-4471-3777-1_2 · Cited by 3
Kinins : important regulators in inflammation induced bone resorption
Brechter, A. B. (2006) · Cited by 3
Alsassa, S., Lefèvre, T., Laugier, V., Stindel, É., & Ansart, S. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00026 · Cited by 2
Rauner, M., & Hofbauer, L. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-34238-2_1 · Cited by 2
HIF-1α activation impairs dendrites formation and elongation in osteocytogenesis
Li, X., Zhao, J. H., Chen, L., Zhou, X., Qiu, M., Deng, L., Yang, K., & Xu, Y. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32889 · Cited by 2
“At the final stage of bone formation, osteoblasts may enter a dormant state as bone lining cells, or undergo programmed cell death, or become deeply embedded in osteoid, where they differentiate into osteocytes [1,2].”
Urbaniak, M. M., Rudnicka, K., Płociński, P., & Chmiela, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413406 · Cited by 2
Linder, C. H. (2016) · Linköping University medical dissertations · doi:10.3384/diss.diva-127100 · Cited by 3
“When an osteoblast stops forming bone, it has three ways to go: i) it can be embedded into the bone matrix and differentiate to an osteocyte [32], ii) it can stay on the bone surface and differentiate to a bone lining cell [33] or, iii) it can undergo programmed cell death (apoptosis) [13].”
Cell Survival and Death in Rheumatic Diseases
Elkon, K. B. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4377-1738-9.00027-x · Cited by 2
Effect of Cyanobacteria (Nostoc species) Extracts on Osteogenesis Activities
Chamnanpuen, P., Satitpatipan, V., Sirisattha, S., & Muangman, T. (2020) · Walailak Journal of Science and Technology (WJST) · doi:10.48048/wjst.2020.5350 · Cited by 2
“At the end of the bone formation phase, osteoblasts can either become embedded in bone as osteocytes, become inactive osteoblasts or bone lining cells [21], or undergo programmed cell death (apoptosis) [21,22].”
BackgroundLian, J. B., & Stein, G. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50007-x · Cited by 2
Osteoimmunology: The Bone-Immune Crosstalk
Chiappelli, F. (2011) · Springer eBooks · doi:10.1007/978-1-4419-9495-0_1 · Cited by 2
Kerschan‐Schindl, K., Nebot, E., & Pietschmann, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-64597-1_153-1 · Cited by 2
Chang, J., Wang, G., Chuang, L., & Ho, M. (2003) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(09)70474-7 · Cited by 2
“Furthermore, TGF-β has an anti-apoptotic effect in osteoblasts [17].”
BackgroundInflammatory Periprosthetic Bone Loss
Lee, S., Edward, P., & Nam, J. (2012) · InTech eBooks · doi:10.5772/25558 · Cited by 1
“…[OB] Effects on osteoclasts [OC] TNF Induces RANKL & M-CSF (Wei et al., 2005) Inhibits OB differentiation & apoptosis (Gilbert et al., 2000; Jilka et al., 1998) Increases OC precursor numbers (Li et al., 2004; Yao et al., 2006) Acts synergistically with RANKL (Lam et al., 2000) IL-1 …”
BackgroundYou, Y., Liu, S., Peng, L., LONG, M., DENG, H., & Zhao, H. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3457 · Cited by 1
Activation of cellular responses to interleukin 6 is blocked by staurosporine
Peppard, J. (1999) · Immunopharmacology · doi:10.1016/s0162-3109(99)00083-1 · Cited by 1
Molecular Bases of Osteoporosis in HIV: The Role of the Virus and Antiretroviral Therapy
Gibellini, D., Borderi, M., Vanino, E., Clò, A., Morini, S., Calza, L., Re, M. C., & Viale, P. (2012) · Clinical Reviews in Bone and Mineral Metabolism · doi:10.1007/s12018-012-9133-y · Cited by 1
“In fact, TNF-alpha is an inducer of osteoclast activity and can determine the survival impairment of osteoblasts, whereas IL-6 is involved in the osteoclast differentiation enhancement in presence of M-CSF and RANKL induction [52, 70, 71].”
BackgroundThe Variety of Osteocyte Function
O’Brien, C. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00006-2 · Cited by 1
Bone — Normal Structure and Physiology
Monier‐Faugere, M., Sawaya, B. P., Langub, M. C., & Malluche, H. H. (2002) · Springer eBooks · doi:10.1007/978-1-4471-0667-8_16 · Cited by 1
Cell Survival and Death in Rheumatic Diseases
Elkon, K. B. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10024-5 · Cited by 1
Mundy, G. R., Oyajobi, B. O., Gutierrez, G., Sterling, J. A. R., Padalecki, S. S., Elefteriou, F., & Zhao, M. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50019-6 · Cited by 1
Metadata
- Authors
- Jilka, R. L., Weinstein, R. S., Bellido, T., Parfitt, A. M., & Manolagas, S. C.
- Affiliations
- University of Arkansas Medical Center (US)
- Corresponding author
- Jilka, Robert L.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-05-01
- Volume
- 13
- Issue
- 5
- Pages
- 793-802
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2075292460
- Cited by
- 578
- References
- 40
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 19 · 2023: 14 · 2022: 10 · 2021: 17 · 2020: 12 · 2019: 16 · 2018: 21 · 2017: 17 · 2016: 17 · 2015: 17 · 2014: 20 · 2013: 21 · 2012: 24
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- Journal of Bone and Mineral Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (P01AG013918)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Keywords
- osteoblast apoptosis, programmed cell death, growth factors, cytokines, TGF-beta, interleukin-6, TNF-α, Fas, Bax/Bcl-2 ratio, oncostatin M, bone remodeling, osteocytes, bone lining cells, MC3T3-E1 cells, MG-63 cells, bone microenvironment
- MeSH terms
- Animals, Bone and Bones, Cell Line, Growth Substances, Humans, Osteoblasts, Recombinant Proteins, Tumor Necrosis Factor-alpha, Interleukin-6, Cytokines, Transforming Growth Factor beta, Bone Remodeling, Apoptosis, Receptors, Interleukin-6, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review